NasdaqGM - Delayed Quote USD

Nano-X Imaging Ltd. (NNOX)

9.07 -0.28 (-2.99%)
At close: April 18 at 4:00 PM EDT
8.89 -0.18 (-1.98%)
Pre-Market: 6:04 AM EDT
Loading Chart for NNOX
DELL
  • Previous Close 9.35
  • Open 9.35
  • Bid 9.05 x 800
  • Ask 9.11 x 800
  • Day's Range 9.06 - 9.44
  • 52 Week Range 4.89 - 22.69
  • Volume 810,474
  • Avg. Volume 4,071,625
  • Market Cap (intraday) 524.052M
  • Beta (5Y Monthly) 2.13
  • PE Ratio (TTM) --
  • EPS (TTM) -1.91
  • Earnings Date May 20, 2024 - May 24, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 15.50

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was incorporated in 2018 and is based in Neve Ilan, Israel.

www.nanox.vision

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NNOX

Performance Overview: NNOX

Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NNOX
42.39%
S&P 500
5.06%

1-Year Return

NNOX
41.72%
S&P 500
20.71%

3-Year Return

NNOX
73.07%
S&P 500
19.73%

5-Year Return

NNOX
--
S&P 500
47.51%

Compare To: NNOX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NNOX

Valuation Measures

As of 4/19/2024
  • Market Cap

    524.05M

  • Enterprise Value

    435.30M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    51.77

  • Price/Book (mrq)

    2.59

  • Enterprise Value/Revenue

    45.16

  • Enterprise Value/EBITDA

    -6.84

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -15.78%

  • Return on Equity (ttm)

    -29.49%

  • Revenue (ttm)

    9.9M

  • Net Income Avi to Common (ttm)

    -60.78M

  • Diluted EPS (ttm)

    -1.91

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    82.38M

  • Total Debt/Equity (mrq)

    4.29%

  • Levered Free Cash Flow (ttm)

    -36.52M

Research Analysis: NNOX

Analyst Price Targets

14.00
15.50 Average
9.07 Current
18.00 High
 

Fair Value

Overvalued
% Return
9.07 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

People Also Watch